MeiraGTx (MGTX)
(Delayed Data from NSDQ)
$5.09 USD
+0.08 (1.60%)
Updated Apr 19, 2024 03:59 PM ET
After-Market: $5.10 +0.01 (0.20%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth B Momentum F VGM
Fundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
MGTX 5.09 +0.08(1.60%)
Will MGTX be a Portfolio Killer in April?
Zacks Investment Research is releasing its prediction for MGTX based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for MGTX
MeiraGTx Holdings PLC (MGTX) Reports Q4 Loss, Misses Revenue Estimates
Praxis Precision Medicines, Inc. (PRAX) Reports Q4 Loss, Tops Revenue Estimates
MGTX: What are Zacks experts saying now?
Zacks Private Portfolio Services
Strength Seen in Lifecore Biomedical (LFCR): Can Its 16.0% Jump Turn into More Strength?
Wall Street Analysts Think MeiraGTx Holdings PLC (MGTX) Could Surge 217.92%: Read This Before Placing a Bet
MeiraGTx (MGTX): Strong Industry, Solid Earnings Estimate Revisions
Other News for MGTX
MeiraGTx Announces Oral Presentation at the 2024 American Academy of Oral Medicine (AAOM) Annual Conference
MeiraGTx Holdings Breaks Above 200-Day Moving Average - Bullish for MGTX
Buy Rating Affirmed: Meiragtx Holdings’ Promising Pipeline and Strategic Partnerships Set Stage for Growth
RBC Capital Sticks to Their Buy Rating for Meiragtx Holdings (MGTX)
MGTX Crosses Below Key Moving Average Level